U.S. Personal Products Stock News

In recent days, several analysts reaffirmed positive views on Shoals Technologies Group, highlighting strengthening Battery Energy Storage System bookings and a growing order backlog following the appointment of David Van Bibber as Chief Accounting Officer. This combination of expanding BESS demand and leadership changes points to evolving business priorities that investors may see as important for Shoals’ long-term positioning. Now we'll explore how stronger BESS bookings and a record...

In recent days, analysts at Mizuho and Wells Fargo reiterated positive views on Mondelez International while flagging tougher competition and economic uncertainty, and investors have increased short interest in the stock to 40.16 million shares, or 3.49% of the float, below the sector average. At the same time, Mondelez has drawn interest from long-term investors such as Oakmark Global Fund, which views the company as a global snacking leader with strong pricing power and potential margin...

Westlake Royal Building Products, part of Westlake, recently showcased roofing brands and installation clinics at the 2026 International Roofing Expo, while Westlake completed its purchase of ACI/Perplastic Group’s global compounding solutions businesses across Portugal, Romania and Tunisia. This acquisition broadens Westlake’s Housing & Infrastructure Products reach in Europe and North Africa, potentially reshaping how investors view the balance between its building-products and...

Northern Trust recently confirmed that it has retained and expanded its more than 20-year mandate with Sweden’s AMF Tjanstepension AB, remaining custodian for AMF’s global pension assets while adding investment operations and trade services across the pension and fund company portfolios. This deepened relationship with a large pension client, alongside Northern Trust Asset Management’s new long-term Capital Market Assumptions, highlights how the group is aligning its asset servicing and...

If you are wondering whether Champion Homes at around US$96 per share is still reasonably priced or looking stretched, this article walks through what the numbers say about its current value. The stock has recently posted a 1.0% return over the last 7 days, 10.7% over the last 30 days, 13.4% year to date, 6.3% over 1 year, 68.7% over 3 years and 174.7% over 5 years. This naturally raises questions about how much of this performance is already reflected in the price. Recent news coverage has...

Market reaction to price drop and insider activity Dave (DAVE) is drawing attention today after a 12% share price drop on heavy trading volume, as investors weigh extensive insider share sales over the past six months and shifting institutional positions. See our latest analysis for Dave. The sharp 7 day share price return of negative 18.9% and wider year to date share price return of negative 11.6% contrast with a very large 3 year total shareholder return. This suggests strong long term...

VisionWave Holdings (VWAV) has drawn fresh attention after Solar Drone Ltd, its wholly owned subsidiary, secured a follow-on hardware order and a new distribution agreement covering Italy and Spain for drone-enabled infrastructure services. See our latest analysis for VisionWave Holdings. The recent news pipeline, from the Solar Drone expansion across Italy and Spain to the RF technology LOI with SaverOne and the new JV platform, has come alongside a sharp pullback, with a 1 day share price...

Wondering if Texas Instruments at around US$191.58 a share offers good value today, or if the price already reflects most of the opportunity. The stock has returned 0.7% over the past week, 8.7% over the last month, 7.9% year to date, 2.8% over 1 year, 21.3% over 3 years and 27.8% over 5 years, which gives you a range of entry points to think about. Recent coverage around Texas Instruments has focused on its position as a large US semiconductor company and how investors are weighing that...

Figure Technology Solutions (FIGR) is back in focus after launching its On-Chain Public Equity Network, or OPEN. The company also reported Q4 2025 consumer loan marketplace volumes that came in more than 20% above one research firm’s forecast. See our latest analysis for Figure Technology Solutions. Those OPEN headlines and stronger than expected consumer loan volumes have been mirrored in the share price, with Figure Technology Solutions posting a 1 month share price return of 75.10% and a...

If you are wondering whether EMCOR Group's current share price lines up with its underlying value, you are not alone. The stock most recently closed at US$698.69, with returns of 8.1% over 7 days, 14.3% over 30 days, 9.4% year to date, 38.2% over 1 year, 384.8% over 3 years and a very large gain over 5 years. Recent coverage has focused on EMCOR Group's position as a major player in electrical and mechanical construction, as well as facilities services across the US. This attention helps...

If you are wondering whether Zions Bancorporation National Association is priced attractively right now, you are in the right place to make sense of what the current share price might be offering you. The stock last closed at US$59.62, with a 1% decline over the past week and a 0.5% slip over the last month, while the 1 year return sits at 6.2% and the 5 year return at 47.0%. Recent price moves are drawing attention back to how regional banks are being valued, with investors weighing up...

Carrier Global (CARR) is back in focus as its Chairman and CEO increases personal shareholdings and institutions like PineStone Asset Management add exposure, just as the company approaches its upcoming quarterly earnings announcement. See our latest analysis for Carrier Global. At a share price of US$56.19, Carrier Global has seen a 4.5% 30 day share price return and a 5% year to date share price return. Its 1 year total shareholder return of an 18.5% decline contrasts with 3 and 5 year...

Arrowhead Pharmaceuticals recently reported interim Phase 1/2a results for its obesity candidates ARO-INHBE and ARO-ALK7 and, through its partnership structure, secured a third major regulatory approval for REDEMPLO (plozasiran) for familial chylomicronemia syndrome, with the latest authorization granted by China’s National Medical Products Administration. Alongside these clinical and regulatory milestones, Arrowhead raised fresh capital via a roughly US$200 million follow-on equity offering...

Blackstone Mortgage Trust (BXMT) is in focus after affiliate Blackstone Real Estate, together with its partners, secured Paramount Television Studios as the first tenant at Manhattan’s new Sunset Pier 94 Studios ahead of its opening. See our latest analysis for Blackstone Mortgage Trust. The Paramount lease lands at a time when Blackstone Mortgage Trust’s share price has been relatively steady at around $19.62, with a 90 day share price return of 9.73% and a 1 year total shareholder return of...

Banco Latinoamericano de Comercio Exterior (Bladex) recently announced it had hosted a virtual investor day on March 24, 2026, where leadership reviewed progress on its 2022–2026 plan and outlined its roadmap through 2030. A key theme from the event was Bladex’s push to evolve from a specialized trade lender into a broader transactional trade banking platform for Latin America, emphasizing scalable, technology-enabled, fee-based services. We’ll now examine how Bladex’s shift toward a...

If you are wondering whether Alcoa's current share price still offers value after a strong run, this article walks through what the numbers are saying about the stock today. At a last close of US$60.07, the stock has seen a 5.7% decline over the past week, a 17.2% gain over the last 30 days, a 6.2% gain year to date and a 53.9% gain over the past year, with a 22.1% gain over 3 years and a very large 5 year return. Recent market commentary around Alcoa has focused on its role as a major...

Why Scotts Miracle-Gro stock is drawing fresh attention Scotts Miracle-Gro (SMG) is back on many investors’ watchlists after recent trading showed mixed returns, with gains over the past month and past 3 months contrasted by a 1 year total return decline. See our latest analysis for Scotts Miracle-Gro. The recent 30 day share price return of 8.44% and 90 day share price return of 16.67% suggest momentum has been improving, even though the 1 year total shareholder return shows a 5.27% decline...

NextDecade (NEXT) is back in focus after fresh commentary on its Rio Grande LNG project, which is framed as a potential long term supplier to Europe as the region reduces reliance on Russian gas. See our latest analysis for NextDecade. The latest commentary around Rio Grande LNG and its long term European role arrives after a sharp 1 day share price return of 4.13% and a 7 day share price return of 8.18%. However, the 1 year total shareholder return of a 41.87% decline shows momentum has been...

If you are wondering whether MongoDB's current share price lines up with its long term potential, you are not alone. This article will focus squarely on what the numbers say about value. The stock last closed at US$399.76, with returns of 2.0% decline over 7 days, 7.2% decline over 30 days, flat performance year to date, and 57.9% over 1 year and 102.0% over 3 years. This naturally raises questions about what is already baked into the price. Recent headlines have focused on MongoDB's role as...

Recent commentary around Bunge Global (BG) has focused on a 3.7% annual sales decline over three years, a 19% yearly drop in earnings per share, and concerns about shrinking cash reserves. See our latest analysis for Bunge Global. Despite the earnings pressure, the recent 30 day share price return of 17.86% and 90 day share price return of 10.86% suggest improving momentum. The 1 year total shareholder return of 40.28% points to a much stronger result for investors who stayed invested through...

If you are wondering whether Commercial Metals' recent share price puts it on sale or at a premium, you are not alone. This article will focus on what the current price might imply about value. The stock recently closed at US$74.42, with returns of 2.7% over 7 days, 7.1% over 30 days, 3.7% year to date, 49.0% over 1 year and 48.5% over 3 years, while the 5 year return sits at 270.6%. These moves have kept investor attention on Commercial Metals as part of broader interest in materials and...

If you are wondering whether Elevance Health is offering good value right now, it helps to step back and look at how its current share price lines up with its fundamentals. The stock most recently closed at US$374.87, with returns of 0.5% over 7 days, 10.0% over 30 days, 5.8% year to date, a 0.8% decline over 1 year, an 18.2% decline over 3 years, and 27.7% over 5 years. Together, these figures give you a mixed picture of shorter term momentum and longer term results. Recent news coverage...

BOK Financial (BOKF) just closed out FY 2025 with fourth quarter revenue of US$589.6 million and basic EPS of US$2.91, backed by net income of US$177.3 million. Over the past year, revenue has moved from US$523.1 million in Q4 2024 to US$589.6 million in Q4 2025, while trailing twelve month EPS sits at US$9.23. With a net interest margin of 2.98% and a cost to income ratio of 64.89% in the latest quarter, the focus this season is on how efficiently the bank is turning that top line into...

If you are wondering whether FactSet Research Systems at around US$288.60 is priced fairly or not, you are not alone. This article is designed to help you make sense of that question. The stock has been fairly flat over the last month with a 0.0% 30-day return. However, the 1-year return of a 36.9% decline and the 5-year return of a 5.5% decline may have some investors reassessing its growth potential and risk. Recent share price moves sit against a backdrop of ongoing attention on financial...